Thrive Capital Management (Pennsylvania)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Buy |
45,402
+26,464
| +140% | +$2.09M | 1.13% | 18 |
|
|
2025
Q1 | $1.7M | Sell |
18,938
-8,252
| -30% | -$741K | 1.02% | 28 |
|
|
2024
Q4 | $2.7M | Buy |
27,190
+8,956
| +49% | +$891K | 1.24% | 22 |
|
|
2024
Q3 | $2.07M | Buy |
18,234
+15,007
| +465% | +$1.7M | 0.98% | 23 |
|
|
2024
Q2 | $400K | Buy |
3,227
+375
| +13% | +$46.4K | 0.18% | 140 |
|
|
2024
Q1 | $376K | Sell |
2,852
-790
| -22% | -$104K | 0.2% | 70 |
|
|
2023
Q4 | $397K | Buy |
3,642
+447
| +14% | +$48.7K | 0.21% | 78 |
|
|
2023
Q3 | $329K | Buy |
3,195
+132
| +4% | +$13.6K | 0.18% | 91 |
|
|
2023
Q2 | $353K | Buy |
3,063
+812
| +36% | +$93.7K | 0.2% | 86 |
|
|
2023
Q1 | $238K | Sell |
2,251
-1,907
| -46% | -$202K | 0.15% | 111 |
|
|
2022
Q4 | $461K | Sell |
4,158
-388
| -9% | -$43K | 0.3% | 65 |
|
|
2022
Q3 | $391K | Buy |
4,546
+777
| +21% | +$66.8K | 0.26% | 66 |
|
|
2022
Q2 | $344K | Buy |
+3,769
| New | +$344K | 0.24% | 70 |
|